SolarWinds, Inc. (NYSE: SWI), Harmonic (NASDAQ: HLIT), BMC Software, Inc. (NYSE: BMC), The Western Union Company (NYSE: WU), Amtrust Financial Services, Inc. (NASDAQ: AFSI) and Quest Software, Inc. (NASDAQ: QSFT) getting new coverage from analysts.
Jefferies (NYSE:JEF) initiated coverage on SolarWinds, Inc. (SWI). They placed a “Buy” rating and a price target of $27.00 on the company.
Kaufman Brothers initiated coverage on Harmonic (HLIT). They placed a “Hold” rating and a price target of $6.50 on the company.
Jefferies initiated coverage on BMC Software, Inc. (BMC). They placed a “buy” rating and a $53.00 price target on the company.
Sterne Agee initiated coverage on The Western Union Company (WU). They placed a “buy” rating and a price target of $21.00 on the company.
SunTrust (NYSE:STI) initiated coverage on Amtrust Financial Services, Inc. (AFSI). They placed a “Buy” rating on the company.
Jefferies initiated coverage on Quest Software, Inc. (QSFT). They placed a “Hold” rating and a price target of $16.00 on the company.
Showing posts with label AmTrust Financial. Show all posts
Showing posts with label AmTrust Financial. Show all posts
Friday, August 19, 2011
Tuesday, August 2, 2011
Amtrust (AFSI) (ANTH) (OII) (RDEN) (SKH) (SUNH) Downgraded
Amtrust Financial Services, Inc. (NASDAQ: AFSI), Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), Oceaneering International (NYSE: OII), Elizabeth Arden, Inc. (NASDAQ: RDEN), Skilled Healthcare Group, Inc. (NYSE: SKH) and Sun Healthcare Group, Inc. (NASDAQ: SUNH) downgraded by analysts.
Amtrust Financial Services, Inc. (AFSI) was downgraded by Keefe, Bruyette & Woods, Inc from an “Outperform” rating to a “Market Perform” rating.
Anthera Pharmaceuticals, Inc. (ANTH) was downgraded by Wedbush from an “Outperform” rating to a “Neutral” rating. They have a price target of $7.00 on the company, down from $9.00.
Oceaneering International (OII) was downgraded by Credit Suisse (NYSE:CS) from an “Outperform” rating to a “Neutral” rating. They have a price target of $48.00 on the company.
Elizabeth Arden, Inc. (RDEN) was downgraded by SunTrust (NYSE:STI) from a “Buy” rating to a “Neutral” rating.
Skilled Healthcare Group, Inc. (SKH) was downgraded by Morgan Keegan from an “Outperform” rating to a “Market Perform” rating. They have a price target of $6.75 on the company, down from $14.00.
Sun Healthcare Group, Inc. (SUNH) was downgraded by Morgan Keegan from an “Outperform” rating to a “Market Perform” rating. They have a price target of $4.00 on the company, down from $11.00.
Amtrust Financial Services, Inc. (AFSI) was downgraded by Keefe, Bruyette & Woods, Inc from an “Outperform” rating to a “Market Perform” rating.
Anthera Pharmaceuticals, Inc. (ANTH) was downgraded by Wedbush from an “Outperform” rating to a “Neutral” rating. They have a price target of $7.00 on the company, down from $9.00.
Oceaneering International (OII) was downgraded by Credit Suisse (NYSE:CS) from an “Outperform” rating to a “Neutral” rating. They have a price target of $48.00 on the company.
Elizabeth Arden, Inc. (RDEN) was downgraded by SunTrust (NYSE:STI) from a “Buy” rating to a “Neutral” rating.
Skilled Healthcare Group, Inc. (SKH) was downgraded by Morgan Keegan from an “Outperform” rating to a “Market Perform” rating. They have a price target of $6.75 on the company, down from $14.00.
Sun Healthcare Group, Inc. (SUNH) was downgraded by Morgan Keegan from an “Outperform” rating to a “Market Perform” rating. They have a price target of $4.00 on the company, down from $11.00.
Tuesday, January 25, 2011
AmTrust Financial's (NASDAQ:AFSI) Not Relevant to EPS Going Forward
While FBR continues to be high on the management team at AmTrust Financial (NASDAQ:AFSI), as well as their foray into Life Settlements. The lumpiness of the segment probably won't do much, if anything, to increase the EPS of the company though.
FBR says, "We believe that AmTrust and its founders (i.e., Karfunkel brothers and Barry Zyskind) arguably are some of the most opportunistic and most successful investors the insurance industry has ever seen. Naturally, we view AmTrust’s foray into the life settlement business in 3Q10 positively. This venture has been three years in the making, as the company brought in a team of experts several years ago.... Due to the lumpiness of revenues associated with life settlements, we do not include any potential benefit to operating EPS estimates going forward."
FBR Capital reiterates an "Outperform" rating on AmTrust Financial (AFSI), which closed Monday at $17.92, the same as their last close. FBR has a price target of $24 on AFSI.
FBR says, "We believe that AmTrust and its founders (i.e., Karfunkel brothers and Barry Zyskind) arguably are some of the most opportunistic and most successful investors the insurance industry has ever seen. Naturally, we view AmTrust’s foray into the life settlement business in 3Q10 positively. This venture has been three years in the making, as the company brought in a team of experts several years ago.... Due to the lumpiness of revenues associated with life settlements, we do not include any potential benefit to operating EPS estimates going forward."
FBR Capital reiterates an "Outperform" rating on AmTrust Financial (AFSI), which closed Monday at $17.92, the same as their last close. FBR has a price target of $24 on AFSI.
Friday, January 14, 2011
AmTrust Financial (NASDAQ:AFSI) EPS Estimates Lowered by FBR
FBR Capital lowered their EPS estimates on AmTrust Financial (NASDAQ:AFSI), although they still consider the share price cheap.
FBR says, "While we continue to rate AmTrust an Outperform, we are lowering our 2010 operating EPS estimate to $2.20 (from $2.30) and decreasing our 2011 forecast to $2.40 (from $2.50)...We believe that our new earnings estimates likely will underestimate AmTrust's long-term earnings potential, as they do not reflect the life settlement contracts business and the investment in ACAC.
"At 7.4x forecasted 2011 EPS, AmTrust remain one of the cheapest names in our coverage universe. In addition, the company's 2010E ROE of 20.6% and 2011E ROE of 18.3% are among the highest in our coverage. As we have said numerous times, for a significant portion of its business, AmTrust functions like a managing general agent (MGA) or insurance broker, effectively earning fee income for its services. As such, the traditional price-to-book value metric does not fully capture the intrinsic value of AmTrust, in our opinion, given the lack of capital requirements for this segment of the company's business."
FBR Capital maintains an "Outperform" rating on AmTrust Financial, which closed Thursday at $17.75, up $0.03, or 0.17 percent. They lowered their price target on AmTrust from $25 to $24.
FBR says, "While we continue to rate AmTrust an Outperform, we are lowering our 2010 operating EPS estimate to $2.20 (from $2.30) and decreasing our 2011 forecast to $2.40 (from $2.50)...We believe that our new earnings estimates likely will underestimate AmTrust's long-term earnings potential, as they do not reflect the life settlement contracts business and the investment in ACAC.
"At 7.4x forecasted 2011 EPS, AmTrust remain one of the cheapest names in our coverage universe. In addition, the company's 2010E ROE of 20.6% and 2011E ROE of 18.3% are among the highest in our coverage. As we have said numerous times, for a significant portion of its business, AmTrust functions like a managing general agent (MGA) or insurance broker, effectively earning fee income for its services. As such, the traditional price-to-book value metric does not fully capture the intrinsic value of AmTrust, in our opinion, given the lack of capital requirements for this segment of the company's business."
FBR Capital maintains an "Outperform" rating on AmTrust Financial, which closed Thursday at $17.75, up $0.03, or 0.17 percent. They lowered their price target on AmTrust from $25 to $24.
Subscribe to:
Posts (Atom)